Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07838077

Modified SOLTIVE Study

This is a study to collect procedural data during the use of the SOLTIVE™ Premium SuperPulsed Laser System in the treatment of bladder, ureteral, and kidney stones and BPH to inform the development of software algorithms.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

About this study

This prospective, observational study is being conducted to collect real-world procedural data and visual recordings during routine standard of care (SOC) urology procedures. These data will be used to support the research and development of future algorithmic software for the SOLTIVE™ Laser System with features designed to recognize anatomical structures and procedural contexts.

The purpose of this study is limited to passive data acquisition and does not involve the clinical use of algorithmic decision support, modification of laser behavior, or changes to procedural technique or patient management. Patients undergoing SOC lithotripsy for bladder, ureter, and kidney calculi (colloquially called "stones") and patients undergoing soft tissue procedures for benign prostatic hyperplasia (BPH) will be considered for inclusion in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Willing and able to provide informed consent
  • ≥ 18 years of age
  • The subject is presenting for the treatment of at least one of the following: a. Bladder, ureter, or kidney stones requiring endoscopic laser lithotripsy as determined by the Investigator b. BPH requiring surgical management with laser enucleation or vaporization of the prostate as determined by the Investigator c. Failed or unwilling to undergo medical (non-surgical) treatment of BPH

Exclusion criteria

  • Concurrently participating in another competing clinical study
  • Contraindicated for endoscopic laser lithotripsy as determined by the Investigator
  • Subject is undergoing percutaneous nephrolithotomy (PCNL) or mini-PCNL
  • Subject presents will bladder stone(s) only
  • Subject presents with ureteral stricture disease or any anatomical abnormalities of the urinary system
  • Subject presents an active infection of the urinary tract (UTI) or sepsis of any origin
  • Subject is contraindicated for laser enucleation or ablation of the prostate as determined by the Investigator
  • Subject presents with prostate glands ≥ 200 grams
  • Subject is pregnant or breast feeding

Treatment and study plan

SOLTIVE Premium SuperPulsed Laser System

Device

The SOLTIVE™ Premium SuperPulsed Laser System is a thulium fiber laser (TFL) for lithotripsy and soft tissue ablation and enucleation procedures in the treatment of renal and urinary calculi and benign prostatic hyperplasia.

Primary outcomes

  1. Safety Measure

    Time frame: From enrollment to the resolution of the adverse event, assessed up to 30 days.

    Incidence of procedure-related adverse events (AEs), serious adverse events (SAEs), and device deficiencies occurring during standard-of-care procedures performed using the Modified SOLTIVE Laser System, including assessment of relatedness to the investigational data-collection components.

  2. Feasibility Measure

    Time frame: From procedural data collection to data entry, assessed up to 10 days.

    Proportion of enrolled subjects with a complete and evaluable procedural dataset, defined as successful collection of SOLTIVE laser procedural data, spectral log data, and endoscopic procedural video data.

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Olympus Corporation of the Americas

Industry

Registry information

Official study title

Real World Data Collection With an Investigational Device for Developing and Evaluating the Clinical Performance of Algorithms in Thulium Fiber Laser Procedures

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 24, 2026
Registry last updated
Sep 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.